Manufacturer record
Morepen Laboratories Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
10 batches manufactured by Morepen Laboratories Ltd (Himachal Pradesh) were declared Not of Standard Quality between May 2020 and August 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: F4L0950, Rabeprazole Gastro-resistant Tablets IP 20 mg (exp Nov 2026). CDTL, Mumbai (CDSCO lab) found it not of standard quality: Dissolution. Listed in the August 2025 alert.
Records by type
10 records linked to Morepen Laboratories Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Rabeprazole Gastro-resistant Tablets IP 20 mg | Batch F4L0950Mfg Dec 2024 · Exp Nov 2026 | DissolutionDissolution | CDTL, MumbaiCDSCO lab | Aug 2025 |
| AMLOPEN 2.5 (Amlodipine Besylate Tablets I.P. 2.5 mg) | Batch E4B0148Mfg Feb 2024 · Exp Jan 2026 | The sample does not conform to standard quality in respect of the test for ?Dissolution? performedDissolution | State Drugs Testing Laboratory, Agartala, TripuraState lab | Jul 2025 |
| Domperidone Tablets IP 10 mg (Domipen Tablets) | Batch E2K0571Mfg Nov 2022 · Exp Oct 2024 | Identification AIdentification | RDTL ChandigarhState lab | Mar 2024 |
| CalciQuick-500 (Calcium and Vitamin D3 Tablets I.P.) | Batch T-1B0038Mfg Feb 2021 · Exp Jan 2023 | Identification & Assay of Vitamin D3Assay | CDL KolkataCDSCO lab | Jul 2022 |
| MONTELUKAST TABLETS IP 10 MG | Batch C-1D0342Mfg Apr 2021 · Exp Mar 2023 | DissolutionDissolution | RDTL ChandigarhCDSCO lab | Jun 2022 |
| CalciQuick-500 (Calcium and Vitamin D3 Tablets I.P.) | Batch T-1H0250Mfg Aug 2021 · Exp Jul 2023 | Assay of Vitamin D3Assay | CDL KolkataCDSCO lab | Apr 2022 |
| BISACODYL GASTRO - RESISTANT TABLETS IP 5 MG | Batch C-0L0933Mfg Dec 2020 · Exp Nov 2022 | DissolutionDissolution | RDTL ChandigarhCDSCO lab | Sep 2021 |
| Orvastin-40 (Atorvastatin Tablets I.P. 40 mg) | Batch P-0C0154Mfg Mar 2020 · Exp Aug 2022 | DissolutionDissolution | CDTL MumbaiCDSCO lab | Jul 2021 |
| ORVASTIN-20 (Atorvastatin Tablets IP 20 mg) | Batch P-0H0440Mfg Aug 2020 · Exp Jan 2023 | DissolutionDissolution | CDTL MumbaiCDSCO lab | Apr 2021 |
| ReGermina (Prebiotic & Probiotics Capsules) | Batch P90087Mfg Feb 2019 · Exp Jun 2020 | Content of Streptococcu s faecalis and Clostridium butyricumOther | CDL KolkataCDSCO lab | May 2020 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.